Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Kinnate Biopharma Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Kinnate Biopharma Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Kinnate Biopharma Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Kinnate Biopharma Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Kinnate Biopharma Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Kinnate Biopharma Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Kinnate Biopharma Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Kinnate Biopharma Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Kinnate Biopharma Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Checkmate Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Checkmate Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Checkmate Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Checkmate Pharmaceuticals, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Kinnate Biopharma Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Clovis Oncology, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Clovis Oncology, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Clovis Oncology, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Loxo Oncology, Inc.Listing unverified | OtherD (derivative) | $1.8M | SEC | ||
Loxo Oncology, Inc.Listing unverified | OtherD (derivative) | $7.6M | SEC | ||
Loxo Oncology, Inc.Listing unverified | OtherD (derivative) | $2.9M | SEC | ||
Loxo Oncology, Inc.Listing unverified | OtherD (derivative) | $7.4M | SEC | ||
Loxo Oncology, Inc.Listing unverified | Other | $2.3M | SEC | ||
Loxo Oncology, Inc.Listing unverified | OtherD (derivative) | $2.1M | SEC | ||
Loxo Oncology, Inc.Listing unverified | OtherD (derivative) | $16.1M | SEC | ||
Loxo Oncology, Inc.Listing unverified | OtherD (derivative) | $3.7M | SEC |